novartis - dofaq.co
New, serious safety risk related to MorphoSys' cancer drug complicates, potentially threatens, Novartis acquisition
STAT - 28 Apr 2024
New, serious safety risk related to MorphoSys' cancer drug complicates, potentially threatens, Novartis acquisition ...
Morphosys says takeover by Novartis on course after report of drug safety concern
Reuters - 29 Apr 2024
Morphosys says takeover by Novartis on course after report of drug safety concern ...
Safety Concerns with MorphoSys’ Blood Cancer Drug Could Mar $2.9B Novartis Buy: STAT
BioSpace - 29 Apr 2024
Safety Concerns with MorphoSys’ Blood Cancer Drug Could Mar $2.9B Novartis Buy: STAT ...
New safety risk for MorphoSys drug could complicate Novartis deal - STAT (NASDAQ:MOR)
Seeking Alpha - 29 Apr 2024
New safety risk for MorphoSys drug could complicate Novartis deal - STAT (NASDAQ:MOR) ...
Novartis pays PeptiDream $180M as radiopharma big bang continues
Fierce Biotech - 30 Apr 2024
Novartis pays PeptiDream $180M as radiopharma big bang continues ...
Novartis, PeptiDream Ink Potential $2.7B Deal to Expand Radioligand Discovery Partnership
BioSpace - 30 Apr 2024
Novartis, PeptiDream Ink Potential $2.7B Deal to Expand Radioligand Discovery Partnership ...
MorphoSys AG Set for Novartis Acquisition - TipRanks.com
TipRanks - 29 Apr 2024
MorphoSys AG Set for Novartis Acquisition - TipRanks.com ...
Drugmaker Novartis climbs after guidance rise on sales of blockbuster drugs
CNBC - 23 Apr 2024
Drugmaker Novartis climbs after guidance rise on sales of blockbuster drugs ...
Novartis to cut 680 jobs in product development
Reuters - 09 Apr 2024
Novartis to cut 680 jobs in product development ...
Stock Watch: Novartis And The Changing Face Of Big Pharma
Scrip - 30 Apr 2024
Stock Watch: Novartis And The Changing Face Of Big Pharma ...
PeptiDream Expands Peptide Discovery Collaboration With Novartis
Contract Pharma - 30 Apr 2024
PeptiDream Expands Peptide Discovery Collaboration With Novartis ...
PeptiDream Announces Expansion of Peptide Discovery Collaboration with Novartis
Business Wire - 30 Apr 2024
PeptiDream Announces Expansion of Peptide Discovery Collaboration with Novartis ...
From black holes to AI driven drug discovery – collaboration wins the day
Novartis - 29 Apr 2024
From black holes to AI driven drug discovery – collaboration wins the day ...
Novartis, Neurocrine-Takeda, Enhertu—Fierce Pharma Asia
FiercePharma - 26 Apr 2024
Novartis, Neurocrine-Takeda, Enhertu—Fierce Pharma Asia ...
Alexion and Novartis/Genentech start UPC's first ever biosimilar disputes
IAM - 24 Apr 2024
Alexion and Novartis/Genentech start UPC's first ever biosimilar disputes ...
Novartis Raises Guidance on Profit, Sales Growth
The Wall Street Journal - 23 Apr 2024
Novartis Raises Guidance on Profit, Sales Growth ...
Novartis accused of promoting asthma drug for preterm labor despite brain risk
Reuters - 23 Apr 2024
Novartis accused of promoting asthma drug for preterm labor despite brain risk ...
Research and development
Novartis - 08 Feb 2024
Research and development ...
Novartis nominates ex-BMS chief Giovanni Caforio as its next chair
FiercePharma - 23 Apr 2024
Novartis nominates ex-BMS chief Giovanni Caforio as its next chair ...